Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$102.39
+0.83%
Mkt Cap $5.00B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (35 analysts)
$116.70
Range $95.00 – $140.00
Implied Upside
+14.0%
Consensus $116.70 vs current $102.39